News
'Remarkable' results in colon cancer trial
Giving colon cancer patients chemotherapy before surgery cuts the risk of the disease coming back, according to the results of a new clinical trial.
New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccination
Patients taking an immunosuppressant drug for rheumatic and musculoskeletal diseases do not appear to be at higher risk of serious outcomes from COVID-19 infection as long as they are vaccinated.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
New research has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Impressive results with long COVID pacing trial
A pacing rehabilitation programme that helps people with long COVID reduce their symptoms and increase activity levels has shown “impressive” results, say scientists.
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer
One in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it, new research has found.